Skip to main content
$4.28 $0.01 (0.2%)

12:48 PM EDT on 10/27/21

Kaleido Biosciences (NASDAQ:KLDO)

CAPS Rating: No stars

Current Price $4.28 Mkt Cap $181.8M
Open $4.29 P/E Ratio 0.00
Prev. Close $4.27 Div. (Yield) $0.00 (0.0%)
Daily Range $4.20 - $4.34 Volume 27,575
52-Wk Range $4.10 - $20.50 Avg. Daily Vol. 135,106

Caps

How do you think NASDAQ:KLDO will perform against the market?

Add Stock to CAPS Watchlist

All Players

7 Outperform
1 Underperform
 

All-Star Players

2 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:KLDO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:KLDO VS S&P 500 (SPY)

NASDAQ:KLDO Summary

Fools bearish on NASDAQ:KLDO are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about KLDO.

Recs

0
Member Avatar LifeScientist (31.82) Submitted: 5/14/2020 2:14:53 PM : Outperform Start Price: $6.62 NASDAQ:KLDO Score: -99.25

Noted outpatient programs and development of support for Covid-19. See 5/14 report. Trading technicals and channels on this one ... buy real world trade on May 14 w 10% price drop.

KB109 when added to Supportive Self-Care for outpatients with mild-to-moderate COVID-19 disease. The program aims to enroll a total of approximately 400 patients in two non-IND controlled clinical studies. Top-line data from the larger, multi-center study are expected in Q4 2020.

COVID-19 infection has been associated with activation of an inappropriate inflammatory cascade, which in some patients can cause an abnormally aggressive immune response that can lead to pneumonia and respiratory failure. Scientific evidence indicates that metabolites such as short chain fatty acids (SCFAs) produced by the microbiome through fermentation of glycans, are modulators of the immune response and therefore could potentially play a role in limiting this inflammatory cascade. KB109 is Generally Recognized as Safe (GRAS) and was selected for evaluation in these COVID-19 clinical studies

Leaderboard

Find the members with the highest scoring picks in KLDO.

Score Leader

TheFall2021

TheFall2021 (86.02) Score: +83.96

The Score Leader is the player with the highest score across all their picks in KLDO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TheFall2021 86.02 1/21/2021 Underperform 5Y $12.29 -65.44% +18.51% +83.96 0 Comment
allforone 92.60 10/4/2021 Outperform 5Y $5.88 -27.76% +6.70% -34.46 0 Comment
stereotyp72 76.42 11/23/2020 Outperform 5Y $7.10 -40.18% +27.66% -67.84 0 Comment
bonjourmesamis 72.63 10/28/2020 Outperform 5Y $6.55 -35.15% +37.32% -72.47 0 Comment
drugtrader 82.57 8/6/2020 Outperform 5Y $6.59 -35.55% +37.51% -73.06 0 Comment
andyy 52.47 10/16/2020 Outperform 1Y $8.67 -51.01% +30.72% -81.73 0 Comment
LucyInTheSky 69.63 9/28/2020 Outperform 5Y $8.93 -52.44% +36.86% -89.29 0 Comment
LifeScientist 31.82 4/24/2020 Outperform 3M $6.62 -35.84% +63.41% -99.25 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for KLDO.